{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:05:51Z","timestamp":1792047951518,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hereditary motor and sensory neuropathy, also referred to as Charcot\u2013Marie\u2013Tooth disease (CMT), is most often caused by a duplication of the peripheral myelin protein 22 (<jats:italic>PMP22<\/jats:italic>) gene. This duplication causes CMT type 1A (CMT1A). CMT1A rarely occurs in combination with other hereditary neuromuscular disorders. However, such rare genetic coincidences produce a severe phenotype and have been reported in terms of \u201cdouble trouble\u201d overlapping syndrome. Waardenburg syndrome (WS) is the most common form of a hereditary syndromic deafness. It is primarily characterized by pigmentation anomalies and classified into four major phenotypes. A mutation in the SRY sex determining region Y-box\u00a010 (<jats:italic>SOX10<\/jats:italic>) gene causes WS type 2 or 4 and peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, WS, and Hirschsprung disease. We describe a 11-year-old boy with extreme hypertrophic neuropathy because of a combination of CMT1A and WS type 2. This is the first published case on the co-occurrence of CMT1A and WS type 2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The 11-year-old boy presented with motor developmental delay and a deterioration in unstable walking at 6\u2009years of age. In addition, he had congenital hearing loss and heterochromia iridis. The neurological examination revealed weakness in the distal limbs with pes cavus. He was diagnosed with CMT1A by the fluorescence in situ hybridization method. His paternal pedigree had a history of CMT1A. However, no family member had congenital hearing loss. His clinical manifestation was apparently severe than those of his relatives with CMT1A. In addition, a whole-body magnetic resonance neurography revealed an extreme enlargement of his systemic cranial and spinal nerves. Subsequently, a genetic analysis revealed a heterozygous frameshift mutation c.876delT (p.F292Lfs*19) in the <jats:italic>SOX10<\/jats:italic> gene. He was eventually diagnosed with WS type 2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We described a patient with a genetically confirmed overlapping diagnoses of CMT1A and WS type 2. The double trouble with the genes created a significant impact on the peripheral nerves system. Severe phenotype in the proband can be attributed to the cumulative effect of mutations in both <jats:italic>PMP22<\/jats:italic> and <jats:italic>SOX10<\/jats:italic> genes, responsible for demyelinating neuropathy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-021-02256-y","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T07:02:38Z","timestamp":1624604558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3773-6778","authenticated-orcid":false,"given":"Nozomu","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushi","family":"Ootsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Usami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Kanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"2256_CR1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41582-019-0254-5","volume":"15","author":"M Pipis","year":"2019","unstructured":"Pipis M, Rossor AM, Laura M, Reilly MM. Next-generation sequencing in Charcot-Marie-tooth disease: opportunities and challenges. Nat Rev Neurol. 2019;15:644\u201356.","journal-title":"Nat Rev Neurol"},{"key":"2256_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2018-318839","volume":"90","author":"A Yoshimura","year":"2019","unstructured":"Yoshimura A, Yuan JH, Hashiguchi A, Ando M, Higuchi Y, Nakamura T, et al. Genetic profile and onset features of 1005 patients with Charcot-Marie-tooth disease in Japan. J Neurol Neurosurg Psychiatry. 2019;90:195\u2013202.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2256_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0092-8674(91)90613-4","volume":"66","author":"JR Lupski","year":"1991","unstructured":"Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-tooth disease type 1A. Cell. 1991;66:219\u201332.","journal-title":"Cell."},{"key":"2256_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0092-8674(93)90058-X","volume":"72","author":"PF Chance","year":"1993","unstructured":"Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 1993;72:143\u201351.","journal-title":"Cell."},{"key":"2256_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/cge.12631","volume":"89","author":"J Song","year":"2016","unstructured":"Song J, Feng Y, Acke FR, Coucke P, Vleminckx K, Dhooge IJ. Hearing loss in Waardenburg syndrome: a systematic review. Clin Genet. 2016;89:416\u201325.","journal-title":"Clin Genet"},{"key":"2256_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.gene.2019.04.023","volume":"704","author":"SB Minami","year":"2019","unstructured":"Minami SB, Nara K, Mutai H, Morimoto N, Sakamoto H, Takiguchi T, et al. A clinical and genetic study of 16 Japanese families with Waardenburg syndrome. Gene. 2019;704:86\u201390.","journal-title":"Gene."},{"key":"2256_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7","volume":"46","author":"K Inoue","year":"1999","unstructured":"Inoue K, Tanabe Y, Lupski JR. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann Neurol. 1999;46:313\u20138.","journal-title":"Ann Neurol"},{"key":"2256_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ng1322","volume":"36","author":"K Inoue","year":"2004","unstructured":"Inoue K, Khajavi M, Ohyama T, Hirabayashi S, Wilson J, Reggin JD, et al. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet. 2004;36:361\u20139.","journal-title":"Nat Genet"},{"key":"2256_CR9","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/ajmg.a.61542","volume":"182","author":"EA Burke","year":"2020","unstructured":"Burke EA, Reichard KE, Wolfe LA, Brooks BP, DiGiovanna JJ, Hadley DW, et al. A novel frameshift mutation in SOX10 causes Waardenburg syndrome with peripheral demyelinating neuropathy, visual impairment and the absence of Hirschsprung disease. Am J Med Genet A. 2020;182:1278\u201383.","journal-title":"Am J Med Genet A"},{"key":"2256_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/gtmb.2014.0252","volume":"19","author":"SY Nishio","year":"2015","unstructured":"Nishio SY, Hayashi Y, Watanabe M, Usami S. Clinical application of a custom AmpliSeq library and ion torrent PGM sequencing to comprehensive mutation screening for deafness genes. Genet Test Mol Biomarkers. 2015;19:209\u201317.","journal-title":"Genet Test Mol Biomarkers"},{"key":"2256_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s004150170159","volume":"248","author":"V Pingault","year":"2001","unstructured":"Pingault V, Bondurand N, Le Caignec C, Tardieu S, Lemort N, Dubourg O, et al. The SOX10 transcription factor: evaluation as a candidate gene for central and peripheral hereditary myelin disorders. J Neurol. 2001;248:496\u20139.","journal-title":"J Neurol"},{"key":"2256_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/jns.12221","volume":"22","author":"P Bogdanova-Mihaylova","year":"2017","unstructured":"Bogdanova-Mihaylova P, Alexander MD, Murphy RPJ, Murphy SM. Waardenburg syndrome: a rare cause of inherited neuropathy due to SOX10 mutation. J Peripher Nerv Syst. 2017;22:219\u201323.","journal-title":"J Peripher Nerv Syst"},{"key":"2256_CR13","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1086\/522090","volume":"81","author":"N Bondurand","year":"2007","unstructured":"Bondurand N, Dastot-Le Moal F, Stanchina L, Collot N, Baral V, Marlin S, et al. Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am J Hum Genet. 2007;81:1169\u201385.","journal-title":"Am J Hum Genet"},{"key":"2256_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1212\/WNL.0000000000001236","volume":"84","author":"EM Yiu","year":"2015","unstructured":"Yiu EM, Brockley CR, Lee KJ, Carroll K, de Valle K, Kennedy R, et al. Peripheral nerve ultrasound in pediatric Charcot-Marie-tooth disease type 1A. Neurology. 2015;84:569\u201374.","journal-title":"Neurology."},{"key":"2256_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ana.24314","volume":"77","author":"K Shibuya","year":"2015","unstructured":"Shibuya K, Sugiyama A, Ito S, Misawa S, Sekiguchi Y, Mitsuma S, et al. Reconstruction magnetic resonance neurography in chronic inflammatory demyelinating polyneuropathy. Ann Neurol. 2015;77:333\u20137.","journal-title":"Ann Neurol"},{"key":"2256_CR16","first-page":"494","volume":"25","author":"TR Aho","year":"2004","unstructured":"Aho TR, Wallace RC, Pitt AM, Sivakumar K. Charcot-Marie-tooth disease: extensive cranial nerve involvement on CT and MR imaging. AJNR Am J Neuroradiol. 2004;25:494\u20137.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2256_CR17","first-page":"378","volume":"20","author":"DD Maki","year":"1999","unstructured":"Maki DD, Yousem DM, Corcoran C, Galetta SL. MR imaging of Dejerine-Sottas disease. AJNR Am J Neuroradiol. 1999;20:378\u201380.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2256_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1001\/archneur.63.1.112","volume":"63","author":"JA Hodapp","year":"2006","unstructured":"Hodapp JA, Carter GT, Lipe HP, Michelson SJ, Kraft GH, Bird TD. Double trouble in hereditary neuropathy: concomitant mutations in the PMP-22 gene and another gene produce novel phenotypes. Arch Neurol. 2006;63:112\u20137.","journal-title":"Arch Neurol"},{"key":"2256_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ana.20434","volume":"57","author":"F Meggouh","year":"2005","unstructured":"Meggouh F, de Visser M, Arts WF, De Coo RI, van Schaik IN, Baas F. Early onset neuropathy in a compound form of Charcot-Marie-tooth disease. Ann Neurol. 2005;57:589\u201391.","journal-title":"Ann Neurol"},{"key":"2256_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2350-14-92","volume":"14","author":"O Schreiber","year":"2013","unstructured":"Schreiber O, Schneiderat P, Kress W, Rautenstrauss B, Senderek J, Schoser B, et al. Facioscapulohumeral muscular dystrophy and Charcot-Marie-tooth neuropathy 1A - evidence for \"double trouble\" overlapping syndromes. BMC Med Genet. 2013;14:92.","journal-title":"BMC Med Genet"},{"key":"2256_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/1389202919666180330153316","volume":"19","author":"V Salpietro","year":"2018","unstructured":"Salpietro V, Manole A, Efthymiou S, Houlden H. A review of copy number variants in inherited neuropathies. Curr Genomics. 2018;19:412\u20139.","journal-title":"Curr Genomics"},{"key":"2256_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/mgg3.390","volume":"6","author":"AN Cutrupi","year":"2018","unstructured":"Cutrupi AN, Brewer MH, Nicholson GA, Kennerson ML. Structural variations causing inherited peripheral neuropathies: a paradigm for understanding genomic organization, chromatin interactions, and gene dysregulation. Mol Genet Genom Med. 2018;6:422\u201333.","journal-title":"Mol Genet Genom Med"},{"key":"2256_CR23","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1212\/01.WNL.0000059262.34846.8A","volume":"60","author":"D Pareyson","year":"2003","unstructured":"Pareyson D, Testa D, Morbin M, Erbetta A, Ciano C, Lauria G, et al. Does CMT1A homozygosity cause more severe disease with root hypertrophy and higher CSF proteins? Neurology. 2003;60:1721\u20132.","journal-title":"Neurology."},{"key":"2256_CR24","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1212\/WNL.49.6.1635","volume":"49","author":"JM Gabriel","year":"1997","unstructured":"Gabriel JM, Erne B, Pareyson D, Sghirlanzoni A, Taroni F, Steck AJ. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Neurology. 1997;49:1635\u201340.","journal-title":"Neurology."},{"key":"2256_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1212\/WNL.48.2.445","volume":"48","author":"A Schenone","year":"1997","unstructured":"Schenone A, Nobbio L, Mandich P, Bellone E, Abbruzzese M, Aymar F, et al. Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies. Neurology. 1997;48:445\u20139.","journal-title":"Neurology."},{"key":"2256_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ydbio.2013.04.024","volume":"382","author":"N Bondurand","year":"2013","unstructured":"Bondurand N, Sham MH. The role of SOX10 during enteric nervous system development. Dev Biol. 2013;382:330\u201343.","journal-title":"Dev Biol"},{"key":"2256_CR27","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1523\/JNEUROSCI.5893-10.2011","volume":"31","author":"EA Jones","year":"2011","unstructured":"Jones EA, Lopez-Anido C, Srinivasan R, Krueger C, Chang LW, Nagarajan R, et al. Regulation of the PMP22 gene through an intronic enhancer. J Neurosci. 2011;31:4242\u201350.","journal-title":"J Neurosci"},{"key":"2256_CR28","first-page":"3055","volume":"25","author":"C Lopez-Anido","year":"2016","unstructured":"Lopez-Anido C, Poitelon Y, Gopinath C, Moran JJ, Ma KH, Law WD, et al. Tead1 regulates the expression of peripheral myelin protein 22 during Schwann cell development. Hum Mol Genet. 2016;25:3055\u201369.","journal-title":"Hum Mol Genet"},{"key":"2256_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/ana.25426","volume":"85","author":"F Tao","year":"2019","unstructured":"Tao F, Beecham GW, Rebelo AP, Svaren J, Blanton SH, Moran JJ, et al. Variation in SIPA1L2 is correlated with phenotype modification in Charcot- Marie- tooth disease type 1A. Ann Neurol. 2019;85:316\u201330.","journal-title":"Ann Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02256-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02256-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02256-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T07:02:53Z","timestamp":1624604573000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02256-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2256"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02256-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institution does not require an ethical approval for the publication of a report on one case. Written informed consent was obtained from the parents of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The parents and sister gave their written informed consent to report the proband\u2019s and his family\u2019s data in a published form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"243"}}